New Green Revolution
Can an innocuous aquatic plant manufacture disease-curing proteins? Drug companies already use genetically engineered bacteria to produce therapeutic proteins such as Factor IX, a blood component that hemophiliacs lack. Others are trying to insert genes into the cells of animals so that the animals can produce specific proteins in their milk.
Anne-Marie Stomp, a professor of forestry at North Carolina State University, says humble duckweed could best both bugs and beasts. The tiny plant may top animals because it is “clonal”-it buds off copies of itself-which means genetic changes will stay intact in succeeding generations. The fast-growing plant can produce more sophisticated proteins than bacteria, says Stomp, and can thrive in an industrial setting. Stomp has started a company, Biolex, to teach the plants to secrete proteins for easy collection.
Keep Reading
Most Popular

The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.

The walls are closing in on Clearview AI
The controversial face recognition company was just fined $10 million for scraping UK faces from the web. That might not be the end of it.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.